Primary dysmenorrhea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants must meet all of the following inclusion criteria to be admitted to this study: (1) 16 to 35 years old (including borders) female; (2) In line with Western medicine primary dysmenorrhea diagnosis; (3) In line with the standard of TCM menstrual syndrome differentiation of abdominal pain; (4) VAS score =4 points before or on the most painful 1 day of each menstrual period in the past 3 months; (5) In the past 3 months there are continuous dysmenorrhea symptoms before or on the day of menstruation; (6) Regular menstrual cycle the cycle is 21-35 days the menstrual period is 3-7 days; (7) Voluntarily participate in this clinical trial give informed consent and sign informed consent.
Exclusion criteria
Exclusion criteria: Subjects with any of the following criteria were excluded from the study: (1) Secondary dysmenorrhea caused by endometriosis, adenomyopathy, and pelvic inflammatory disease; (2) have used painkillers such as non-steroidal anti-inflammatory drugs or other methods to treat dysmenorrhea in the past 1 month; (3) Have used traditional Chinese medicine or proprietary Chinese medicine with the effect of regulating qi and removing blood stasis in the past 1 month; (4) gynecological tumors, uterine fibroids, abortion history, gynecological surgery history; (5) Use of long-acting contraceptives by injection or subcutaneous implantation within 6 months, or use of contraceptives within 8 weeks, use of medicated intrauterine devices, or preparation for pregnancy and pregnancy within 6 months; (6) Combined with serious diseases of other systems, such as liver, kidney, hematopoietic system and other serious primary diseases, tumors, mental diseases, etc.; (7) Suspected or have a history of alcohol or drug abuse; (8) acupoint local skin rupture; (9) Asthmatic patients who are allergic to emergency medication ibuprofen capsules or other non-steroidal anti-inflammatory drugs, or to aspirin; (10) Those who have participated in other clinical trials or received acupuncture, moxibustion, cupping and other physiotherapy within the field of traditional Chinese medicine within the past 1 month; (11) The investigator considers the patient unfit to participate in the study, including the investigator's judgment that the patient cannot complete the study or comply with the requirements of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of dysmenorrhea;NRS score of the most painful degree of dysmenorrhea; | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of days with significant menstrual pain (VAS score =4 points);The use of emergency drugs;Total CMSS score for duration of dysmenorrhea symptoms;Hamilton Anxiety Scale (HAMA);Disappearance rate of dysmenorrhea pain;Dysmenorrhea NRS score time - area under the curve;Total CMSS score of dysmenorrhea symptom severity; | — |
Countries
China
Contacts
Hunan University of Chinese Medicine